Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Retina (Philadelphia, Pa.)|December 26, 2024
THREE-YEAR CLINICAL OUTCOMES IN GEOGRAPHIC ATROPHY: An Analysis of 18,712 Patient EyesAumer Shughoury, Nick Boucher, Nitika Aggarwal, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 15, 2025
Trends and Outcomes of Secondary Intraocular Lens Utilization Among Vitreoretinal Surgeons Compared to Vitreoretinal and Anterior Segment SurgeonsMaria A Bantounou, Nitika Aggarwal, Nicholas Boucher, et al.
American Journal of Ophthalmology|October 25, 2024
Submacular Hemorrhage Rates Following Anti-Vascular Endothelial Growth Factor Injections for Exudative Age-Related Macular DegenerationGabriel T Kaufmann, Nicholas Boucher, Chakshu Sharma, et al.
Journal of Vitreoretinal Diseases|September 25, 2024
Retrospective Large Database Study of Central Serous Chorioretinopathy Treatments and Visual Outcomes Analysis in the United StatesLauren Burgett, Nitika Aggarwal, John Latona, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|March 21, 2023
Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy ProgressionKaren M Wai, Namrata Saroj, Nick Boucher, et al.
Journal of Vitreoretinal Diseases|April 13, 2026
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Anti-vascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Diabetic Macular EdemaNathan N Macha, Lucas W Rowe, Nitika Aggarwal, et al.
Journal of Vitreoretinal Diseases|May 15, 2023
Evolving Treatment Patterns in Diabetic Macular Edema Between 2015 and 2020Guneet S Sodhi, Zeeshan Haq, Nitika Aggarwal, et al.
Journal of Vitreoretinal Diseases|April 13, 2026
Visual Acuity and Durability Outcomes of Faricimab Compared With Other Antivascular Endothelial Growth Factor Agents Within Routine Clinical Practice for Neovascular Age-Related Macular DegenerationLucas W Rowe, Nathan N Macha, Nitika Aggarwal, et al.
Retina (Philadelphia, Pa.)|January 3, 2025
RISK FACTORS FOR PROLIFERATIVE VITREORETINOPATHY IN A LARGE CLINICAL DATABASEDamla Oncel, Samuel Minaker, E Annie Shepherd, et al.
Eye and Vision (London, England)|November 6, 2024
Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degenerationKyle S Chan, Nitika Aggarwal, Shannon Lawson, et al.
Pageof 2